BPC-157 Protects Against Ibuprofen-Induced Liver Damage and Brain Swelling in Rats

BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from NSAID toxicity simultaneously.

Ilic, Spomenko et al.·European journal of pharmacology·2011·
RPEP-017822011RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from NSAID toxicity simultaneously.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from N
Evidence Grade:
emerging evidence.
Study Age:
Published in 2011.
Original Title:
Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.
Published In:
European journal of pharmacology, 667(1-3), 322-9 (2011)
Database ID:
RPEP-01782

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

BPC-157 Protects Against Ibuprofen-Induced Liver Damage and Brain Swelling in Rats

What was found?

BPC-157 counteracted ibuprofen-induced hepatic encephalopathy, hepatomegaly, and gastric lesions in rats — protecting liver, brain, AND stomach from NSAID toxicity simultaneously.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01782·https://rethinkpeptides.com/research/RPEP-01782

APA

Ilic, Spomenko; Drmic, Domagoj; Zarkovic, Kamelija; Kolenc, Danijela; Brcic, Luka; Radic, Bozo; Djuzel, Viktor; Blagaic, Alenka Boban; Romic, Zeljko; Dzidic, Senka; Kalogjera, Livije; Seiwerth, Sven; Sikiric, Predrag. (2011). Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.. European journal of pharmacology, 667(1-3), 322-9. https://doi.org/10.1016/j.ejphar.2011.05.038

MLA

Ilic, Spomenko, et al. "Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.." European journal of pharmacology, 2011. https://doi.org/10.1016/j.ejphar.2011.05.038

RethinkPeptides

RethinkPeptides Research Database. "Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesi..." RPEP-01782. Retrieved from https://rethinkpeptides.com/research/ilic-2011-ibuprofen-hepatic-encephalopathy-hepatomegaly

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.